H.C. Wainwright Reaffirms Their Buy Rating on Voyager Therapeutics (VYGR)
at www.tipranks.com (Thu, 25-Jun 8:36 AM)
Voyager’s VY1706 Gene Therapy Shows Up to 64% Tau Reduction—Alzheimer’s Clinical Trial Slated for Late 2026
Market Chameleon (Thu, 14-May 10:44 AM)
